Evaluation of survivin mRNA antigen lipid nanoparticles and CTLA 4 inhibitor combination for effective oral carcinoma immunotherapy
No Thumbnail Available
Date
2025
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
BITS PILANI, Hyderabad campus
Abstract
Description
Under the Supervision of Prof. Venkata Vamsi Krishna Venuganti
Keywords
PHARMACY, Survivin mRNA antigen, CTLA 4 inhibitor, Oral carcinoma